Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

download_1

Roche to start new trials of Ocrevus to defend multiple sclerosis franchise

September 9, 2020 Research and Development MS, MS drug, Roche

Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
News
china_v_0_1

Major vaccine manufacturers sign COVID-19 safety pledge

September 9, 2020 Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine

Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19.  The companies involved …
News
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Appointment
sanofi_hq__boetie_hall_web

Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma

September 8, 2020 Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma

New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
News
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020 Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
News
shutterstock_159488225

Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety

September 4, 2020 Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat

Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …
News
gustave_perna_29510410783

Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report

September 3, 2020 Research and Development

Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …
News
shutterstock_138095450

Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+

September 2, 2020 Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma

Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …
News
800px-president_trump_delivers_remarks_at_the_white_house_coronavirus_task_force_briefing_49716740721

US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO

September 2, 2020 Research and Development Trump, Trump Administration, US, USA

The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …
News
type_2_diabetes_28081593711_1

Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK

September 2, 2020 Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes

Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
News
shutterstock_273326141

Nestlé to acquire remaining shares in Aimmune for $2.6 billion

September 2, 2020 Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma

Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …
News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 2, 2020 Research and Development

The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …
News
index_ph001

Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020

September 1, 2020 Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma

Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …
News
covid_innovations_bamc_1

Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests

August 27, 2020 Research and Development COVID-19

Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company. 
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026